Research Topics
Species | Adeyinka O LaiyemoSummaryAffiliation: National Institutes of Health Country: USA Publications
| Collaborators
|
Detail Information
Publications
Postpolypectomy colonoscopy surveillance guidelines: predictive accuracy for advanced adenoma at 4 yearsAdeyinka O Laiyemo
Cancer Prevention Fellowship Program, Biometry Research Group, Divisionof Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
Ann Intern Med 148:419-26. 2008..Lack of confidence in postpolypectomy surveillance guidelines may be a factor in the observed low adherence rates among providers...
Atrophic gastritis and the risk of incident colorectal cancerAdeyinka O Laiyemo
Cancer Prevention Fellowship Program, Office of Preventive Oncology, National Cancer Institute NCI, National Institutes of Health NIH, Bethesda, MD, USA
Cancer Causes Control 21:163-70. 2010..We prospectively examined the association of atrophic gastritis, a pre-malignant condition for gastric cancer and long-term sequelae common to many exposure factors, and the risk of incident CRC...
Serum pepsinogen level, atrophic gastritis and the risk of incident pancreatic cancer--a prospective cohort studyAdeyinka O Laiyemo
Cancer Prevention Fellowship Program, Office of Preventive Oncology, National Cancer Institute NCI, National Institutes of Health NIH, Bethesda, MD 20892, USA
Cancer Epidemiol 33:368-73. 2009..We hypothesized that low SPGI level may be associated with an increased risk of pancreatic cancer and be a useful biomarker for the disease...
Upper gastrointestinal bleeding from metastatic testicular cancerAdeyinka O Laiyemo
Cancer Prevention Fellowship Program, Office of Preventive Oncology, Biometry Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, 6130 Executive Blvd, Rm 3121, Bethesda, MD 20892 7354, USA
J Natl Med Assoc 101:808-9. 2009..This also demonstrates the effectiveness of ifosphamide as second-line therapy in the setting of resistance to platinum-based therapy...
Utilization and yield of surveillance colonoscopy in the continued follow-up study of the polyp prevention trialAdeyinka O Laiyemo
Cancer Prevention Fellowship Program, Office of Preventive Oncology, National Cancer Institute, Bethesda, Maryland 20892, USA
Clin Gastroenterol Hepatol 7:562-7; quiz 497. 2009..We examined the use and yield of surveillance colonoscopy among participants in the Polyp Prevention Trial (PPT) after the 4-year dietary intervention trial ended...
Hyperplastic polyps and the risk of adenoma recurrence in the polyp prevention trialAdeyinka O Laiyemo
Cancer Prevention Fellowship Program, Office of Preventive Oncology, National Cancer Institute, Bethesda, Maryland 20892, USA
Clin Gastroenterol Hepatol 7:192-7. 2009..Prospective information on the risk of adenoma recurrence associated with hyperplastic polyps is limited. We sought to investigate whether the coexistence of hyperplastic polyps with adenomas increases the risk of adenoma recurrence...
Metastatic gastric stump cancer occurring six years after a partial gastrectomy for gastric ulcerAdeyinka O Laiyemo
Cancer Prevention Fellowship Program, Biometry Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, MD 20892, USA
J Natl Med Assoc 100:737-9. 2008..We highlight the need for identification of patients at risk of developing gastric stump cancer-especially as it has now been described in patients who underwent gastric bypass surgery for obesity-a population that continues to increase...
Serum adiponectin, leptin, C-peptide, homocysteine, and colorectal adenoma recurrence in the Polyp Prevention TrialGerd Bobe
Laboratory of Cancer Prevention, Center for Cancer Research, National Cancer Institute NCI, NIH, Department of Health and Human Services DHHS, Bethesda, Maryland, USA
Cancer Epidemiol Biomarkers Prev 19:1441-52. 2010..Serum adiponectin, leptin, C-peptide, and homocysteine are indicators for obesity, hyperinsulinemia, and chronic inflammation, which have all been associated with colorectal cancer...
Dopamine D2 receptor polymorphisms and adenoma recurrence in the Polyp Prevention TrialGwen Murphy
Cancer Prevention Fellowship Program, Office of Preventive Oncology, National Cancer Institute, Bethesda, MD 20892, USA
Int J Cancer 124:2148-51. 2009..Increased risk of adenoma recurrence as conferred by DRD2 genotypes may be related to difference in alcohol and fat intake across genotypes...
Non-steroidal anti-inflammatory drugs and colorectal cancer risk in a large, prospective cohortElizabeth H Ruder
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Rockville, Maryland, USA
Am J Gastroenterol 106:1340-50. 2011..We investigated NSAID use and colorectal adenocarcinoma by subsite, and among individuals with a family history of colon cancer in the National Institutes of Health-AARP Diet and Health Study...
Short- and long-term risk of colorectal adenoma recurrence among whites and blacksAdeyinka O Laiyemo
Department of Medicine, Howard University Hospital, Washington, DC, USA
Gastrointest Endosc 77:447-54. 2013..It is unclear whether the higher burden from colorectal cancer among blacks is due to an increased biological susceptibility...
Factors associated with inadequate colorectal cancer screening with flexible sigmoidoscopyAdeyinka O Laiyemo
Division of Gastroenterology, Department of Medicine, Howard University College of Medicine, Washington, DC 20060, USA
Cancer Epidemiol 36:395-9. 2012....
